Categories LATEST
NYU professor who predicted Amazon-Whole Foods deal forecasts death of Tesla, 4 others
All hell broke loose during the weekend when Scott Galloway, a professor who teaches marketing at the NYU Stern School of Business and the author of Digital IQ Index, predicted that electric vehicle pioneer Tesla (NASDAQ: TSLA) would vanish, or lose 80% of its value within the next 10 years.
Even as Tesla fanboys expressed their disapproval of this prediction pointing out a large number of variables, Galloway said the Elon Musk-led firm lacks the scale to operate in a low-margin segment. He feels that the company won’t be able to reach a delivery target, where it starts gaining profits.
Notably, the prediction comes a week after Tesla fell short of market expectations on vehicle deliveries.
Galloway had earlier successfully predicted the merger of Amazon (NASDAQ: AMZN) and Whole Foods, which finally happened in 2017. However, his prior prediction on Tesla, where he said the company would get acquired within 2019 after the stock falls below $100 per share, has not come true.
READ: Softbank’s hopes are now pinned on this rapid-growth “WeWork-like” unicorn
There are four more companies on Galloway’s death list – WeWork, which recently postponed its IPO over overvaluation concerns, Lyft (NASDAQ: LYFT), which had a lackluster IPO, financial services firm Robinhood and the world’s third-largest hotel chain Oyo.
Further, he listed 10 unicorns as overvalued. These were Pinterest (NYSE: PINS), Snap (NYSE: SNAP), Twitter (NYSE: TWTR), Peloton, Slack (NYSE: WORK), DoorDash, Lime, Palantir, Uber (NYSE: UBER) and Compass (NYSE: CODI).
Apart from being a professor, Galloway is also the founder of business intelligence firm L2 Inc, which was bought by Gartner in 2017.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company